Scotiabank Sticks to Bullish Call on Johnson & Johnson Amid Insider Selling

Analyst Louise Chen at Scotiabank has maintained her Buy rating on Johnson & Johnson, setting a price target of $305.00.

Chen is a 4-star analyst with an average return of 4.4% and a success rate of 49.29%. She covers the Healthcare sector, focusing on stocks like Gilead Sciences, Johnson & Johnson, and Merck & Company.

In addition to Scotiabank, Johnson & Johnson has received a Buy rating from Wells Fargo's Larry Biegelsen in a report issued yesterday. However, Bank of America Securities reiterated a Hold rating on the company just last week, citing concerns over corporate insider sentiment.